Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)
Clinical trial NCT04363827 · TERMINATED
Trial details
- NCT number
- NCT04363827
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-14
- Primary completion
- 2021-09-30
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.